RemeGen Co., Ltd.
REGMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,883,491 | $15,705,411 | $51,188,825 | $48,394,991 |
| - Cash | $759,530 | $709,073 | $2,069,180 | $1,756,821 |
| + Debt | $2,670,511 | $1,259,983 | $165,035 | $102,778 |
| Enterprise Value | $7,794,472 | $16,256,321 | $49,284,680 | $46,740,948 |
| Revenue | $1,710,152 | $1,076,130 | $767,775 | $1,423,902 |
| % Growth | 58.9% | 40.2% | -46.1% | – |
| Gross Profit | $1,367,356 | $822,994 | $497,836 | $1,356,739 |
| % Margin | 80% | 76.5% | 64.8% | 95.3% |
| EBITDA | -$1,095,374 | -$1,247,859 | -$805,702 | $402,053 |
| % Margin | -64.1% | -116% | -104.9% | 28.2% |
| Net Income | -$1,468,362 | -$1,511,229 | -$998,830 | $276,258 |
| % Margin | -85.9% | -140.4% | -130.1% | 19.4% |
| EPS Diluted | -2.73 | -2.8 | -1.88 | 0.57 |
| % Growth | 2.5% | -48.9% | -429.8% | – |
| Operating Cash Flow | -$1,176,596 | -$1,501,829 | -$1,263,689 | $263,631 |
| Capital Expenditures | -$265,282 | -$852,739 | -$757,517 | -$617,340 |
| Free Cash Flow | -$1,441,878 | -$2,354,568 | -$2,021,206 | -$353,709 |